Rhythm Pharmaceuticals (RYTM) Capital Expenditures (QoQ) (2018 - 2023)
Rhythm Pharmaceuticals (RYTM) Capital Expenditures (QoQ) (2018 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Rhythm Pharmaceuticals |
6.59 Bn |
6.25 Bn |
52.96 Mn |
| Date | Value |
|---|
| Dec 31, 2023 |
-200.00% |
| Mar 31, 2023 |
4,800.00% |
| Dec 31, 2022 |
-101.05% |
| Sep 30, 2022 |
58.33% |
| Jun 30, 2022 |
-52.76% |
| Mar 31, 2022 |
86.76% |
| Dec 31, 2021 |
-35.85% |
| Sep 30, 2021 |
-57.26% |
| Jun 30, 2021 |
1,966.67% |
| Mar 31, 2021 |
-85.71% |
| Sep 30, 2019 |
-88.81% |
| Jun 30, 2019 |
185.45% |
| Mar 31, 2019 |
105.32% |
| Dec 31, 2018 |
24.61% |
